SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

HIV and fungal priority pathogens.

Sati, H; Alastruey-Izquierdo, A; Perfect, J; Govender, NP; Harrison, TS; Chiller, T; Sorrell, TC; Bongomin, F; Oladele, R; Chakrabarti, A; et al. Sati, H; Alastruey-Izquierdo, A; Perfect, J; Govender, NP; Harrison, TS; Chiller, T; Sorrell, TC; Bongomin, F; Oladele, R; Chakrabarti, A; Wahyuningsih, R; Colombo, AL; Rodriguez-Tudela, JL; Beyrer, C; Ford, N (2023) HIV and fungal priority pathogens. Lancet HIV, 10 (11). e750-e754. ISSN 2352-3018 https://doi.org/10.1016/S2352-3018(23)00174-1
SGUL Authors: Harrison, Thomas Stephen

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (184kB) | Preview

Abstract

The burden of invasive fungal infections associated with opportunistic fungal pathogens is a persistent challenge, particularly among people with advanced HIV disease. In October, 2022, WHO published the Fungal Priority Pathogens List (FPPL)-the first global effort to systematically prioritise fungal pathogens. Of the 19 pathogens in the WHO FPPL, four opportunistic pathogens in particular cause invasive diseases in people living with HIV: Cryptococcus neoformans, Histoplasma spp, Pneumocystis jirovecii, and Talaromyces marneffei. These four fungal pathogens are major causes of illness and death in people with advanced HIV and overwhelmingly affect those in low-income and middle-income countries. Access to diagnostics, improved surveillance, targeted support for innovation, and an enhanced public health focus on these diseases are needed in the effort to reduce HIV-associated deaths.

Item Type: Article
Additional Information: © 2023. This EPMC manuscript version is made available under the CC-BY 4.0 license https://creativecommons.org/licenses/by/4.0/
Keywords: Humans, HIV Infections, Histoplasma, Humans, Histoplasma, HIV Infections, 11 Medical and Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Lancet HIV
ISSN: 2352-3018
Language: eng
Dates:
DateEvent
November 2023Published
9 October 2023Published Online
7 July 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 37827187
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115852
Publisher's version: https://doi.org/10.1016/S2352-3018(23)00174-1

Statistics

Item downloaded times since 03 Jan 2024.

Actions (login required)

Edit Item Edit Item